All

AACC Calls on Congress to Cut VALID Act from New Legislation

AACC has urged the U.S. Senate HELP Committee not to include the VALID Act in its omnibus Food and Drug Administration user fee legislation.

The majority (75.8%) of patients diagnosed with a post-COVID condition, also known as long COVID, had never been hospitalized for COVID-19.

A clear set of pandemic prevention and preparedness strategies will be critical for clinical labs to meet the challenges the next event.

AACC has urged the U.S. Senate HELP Committee not to include the VALID Act in its omnibus Food and Drug Administration user fee legislation.

Next-generation point-of-care diagnostics company LumiraDx announced that its quick SARS-CoV-2 Ag Ultra Test achieved CE Marking.

The system automates tasks such as serial dilutions, sample normalization, hit picking or pipetting of complex plate layouts.

A recent study confirmed that scent detection dogs can be taught to identify individuals with a coronavirus infection from skin swabs.

Premier Medical Laboratory Services has added Noninvasive Prenatal Testing to its line of diagnostic testing and risk screening services.

Molecular Devices launched its SpectraMax Mini Multi-Mode Microplate Reader, aimed to save researchers benchtop space and budget.

Verichem Laboratories now offers completely liquid stable clinical reference materials for both total and direct Bilirubin assays.

Accelerate Diagnostics announced the commercialization of its Accelerate Arc system, which includes the Accelerate Arc Module and BC kit.

Detact Diagnostics, a Netherlands-based company that produces bacterial- and viral-detection solutions, is expanding to the U.S.

A retrospective study correlated blood adenosine levels to the development of complications or prematurity.